Friday, May 4, 2018

Experimental Ovarian Cancer Screening Test

Many thanks to Betsy for sending me this article published recently on the National Cancer Institute web page.

The article describes a new screening tool being studied to detect endometrial and ovarian cancer in its early stages.

Called PapSEEK, this liquid biopsy is actually a PAP test that checks for cancer related DNA changes. Preliminary investigations showed that it detected 33% of ovarian cancers (of which 34% were detected in early stages) and ~81% of endometrial cancers (of which 78% were detected in early stages).

These results were first published in the journal Science: Translational Medicine and was reported on the National Cancer Institute web site. Follow this link to read NCI's article.

No comments:

Post a Comment